Found 20 matching trials
A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis PHASE2 This was a randomized, partially blinded, placebo-controlled, non-confirmat...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome PHASE3 A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 s...
Show More Status
Active Not Recruiting
Location
Providence Medical Foundation
Learn More & Join Trial
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia PHASE3 The purpose of this study is to evaluate efficacy and safety of ianalumab c...
Show More Status
Active Not Recruiting
Location
Michigan Center of Medical Research
Learn More & Join Trial
Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome PHASE3 A randomized, double-blind, placebo controlled, 2-arm multicenter phase 3 s...
Show More Location
Medvin Clinical Research
Learn More & Join Trial
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden PHASE3 The purpose of this study is to demonstrate the efficacy and safety of iana...
Show More Location
Sun Valley Arthritis Center Ltd
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients PHASE1 This study investigated the safety and tolerability of VAY736 administered ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) PHASE2 The purpose of this study was to determine the dose-response relationship o...
Show More Location
Integral Rheumatology and Immunology Specialists IRIS
Learn More & Join Trial
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) PHASE3 The purpose of this study is to evaluate the effect of two different doses ...
Show More Status
Active Not Recruiting
Location
Yuma Regional Medical Center
Learn More & Join Trial
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis PHASE2 The purpose of this study is to evaluate efficacy, safety and tolerability ...
Show More Location
Arizona Arthritis and Rheumatology Research PLLC
Learn More & Join Trial
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. PHASE3 The purpose of this study is to measure the long-term safety and tolerabili...
Show More Status
Active Not Recruiting
Location
Providence Medical Foundation
Learn More & Join Trial